Medinotec (MDNC) Non Operating Interest Expenses (2022 - 2026)
Medinotec's (MDNC) quarterly Non Operating Interest Expenses came in at $6868.0 in Q2 2026, down 78.49% on a YoY basis from $31925.0 in Q2 2025, and down 17.05% quarter-over-quarter from $8280.0 in Q1 2026.
Powered by 
Analysis
Medinotec (MDNC) Non Operating Interest Expenses (2022 - 2026) Analysis & Trends
Medinotec (MDNC) has reported Non Operating Interest Expenses for 5 consecutive years, with $6868.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non Operating Interest Expenses fell 78.49% year-over-year to $6868.0; the trailing twelve-month figure through May 2026 stood at $62538.0 (down 58.4% YoY), and the FY2026 full-year result was $87595.0, down 50.35% from the prior year.
- Non Operating Interest Expenses retreated to $6868.0 in Q2 2026 per MDNC's latest filing, from $8280.0 in the prior quarter.
- Across five years, Non Operating Interest Expenses topped out at $64760.0 in Q4 2022 and bottomed at -$387407.0 in Q1 2023.
- Historically, Non Operating Interest Expenses has averaged -$22867.8 across 5 years, with a median of $7698.0 in 2025.
- The sharpest annual moves came in 2023 and 2024: Non Operating Interest Expenses tumbled 3032.9% in 2023, then surged 188.48% in 2024.
- Over 5 years, Non Operating Interest Expenses stood at $64760.0 in 2022, then plunged by 203.04% to -$66727.0 in 2023, then surged by 165.04% to $43400.0 in 2024, then slumped by 83.6% to $7116.0 in 2025, then fell by 3.49% to $6868.0 in 2026.
- According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $6868.0, $8280.0, and $7116.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 186.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 141.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 96.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -53.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Medinotec | 58.78 Mn | 58.19 Mn | 1.31 Mn | 6,868.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 6,868.00 |
| Feb 28, 2026 | 8,280.00 |
| Nov 30, 2025 | 7,116.00 |
| Aug 31, 2025 | 40,274.00 |
| May 31, 2025 | 31,925.00 |
| Feb 28, 2025 | 27,909.00 |
| Nov 30, 2024 | 43,400.00 |
| Aug 31, 2024 | 47,085.00 |
| May 31, 2024 | 58,022.00 |
| Feb 29, 2024 | -74,097.00 |
| Nov 30, 2023 | -66,727.00 |
| Aug 31, 2023 | -70,833.00 |
| May 31, 2023 | -65,573.00 |
| Feb 28, 2023 | -387,407.00 |
| Nov 30, 2022 | 64,760.00 |
| Aug 31, 2022 | -53,412.00 |
| May 31, 2022 | -42,420.00 |
| Feb 28, 2022 | 13,209.00 |